147 related articles for article (PubMed ID: 31066993)
1. Flow cytometry "Ogata score" for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience.
Grille Montauban S; Hernandez-Perez CR; Velloso EDRP; Novoa V; Lorand-Metze I; Gonzalez J; Solari L; Cismondi V; Serrano JC; Burgnini A; Rabelo-Carrasco LJ; Bacal N; Trias N; Guevara R; Rico Vido J; Crisp R; Enrico A; Boada M; Pereira Cunha FG; Fanessi V; Venegas MB; Issouribehere D; Novoa A; Lens D
Int J Lab Hematol; 2019 Aug; 41(4):536-541. PubMed ID: 31066993
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry diagnosis in myelodysplastic syndrome: Current practice in Latin America and comparison with other regions of the world.
Grille S; Iastrebner M; Lorand-Metze I; van der Velden VHJ; Ikoma MRV; Vidal-Senmache G; Colado E; Rabelo-Carrasco LJ; Blanco A; Huamán-Garaicoa F; O'Connor JE; Cao Pochintesta C; Jensen E; Bacal NS; Díaz L; Lens D
Leuk Res; 2019 Apr; 79():69-74. PubMed ID: 30773246
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India.
Dhingra G; Dass J; Arya V; Gupta N; Saraf A; Langer S; Aggarwal S; Kotwal J; Bhargava M
Indian J Med Res; 2020 Sep; 152(3):254-262. PubMed ID: 33107485
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia.
Muyldermans A; Florin L; Devos H; Cauwelier B; Emmerechts J
Hematology; 2019 Dec; 24(1):166-172. PubMed ID: 30334700
[TBL] [Abstract][Full Text] [Related]
5. Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Bardet V; Wagner-Ballon O; Guy J; Morvan C; Debord C; Trimoreau F; Benayoun E; Chapuis N; Freynet N; Rossi C; Mathis S; Gourin MP; Toma A; Béné MC; Feuillard J; Guérin E; ;
Haematologica; 2015 Apr; 100(4):472-8. PubMed ID: 25637056
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes.
Davydova YO; Parovichnikova EN; Galtseva IV; Kokhno AV; Dvirnyk VN; Kovrigina AM; Obukhova TN; Kapranov NM; Nikiforova KA; Glinkina SA; Troitskaya VV; Mikhailova EA; Fidarova ZT; Moiseeva TN; Lukina EA; Tsvetaeva NV; Nikulina OF; Kuzmina LA; Savchenko VG
Cytometry B Clin Cytom; 2021 May; 100(3):312-321. PubMed ID: 33052634
[TBL] [Abstract][Full Text] [Related]
7. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
[TBL] [Abstract][Full Text] [Related]
8. Integration of the Ki-67 proliferation index into the Ogata score improves its diagnostic sensitivity for low-grade myelodysplastic syndromes.
Mestrum SGC; Cremers EMP; de Wit NCJ; Drent RJM; Ramaekers FCS; Hopman AHN; Leers MPG
Leuk Res; 2022 Feb; 113():106789. PubMed ID: 35101793
[TBL] [Abstract][Full Text] [Related]
9. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
[TBL] [Abstract][Full Text] [Related]
10. CD177 Enhances the Detection of Myelodysplastic Syndrome by Flow Cytometry.
Alayed K; Meyerson JB; Osei ES; Blidaru G; Schlegelmilch J; Johnson M; Meyerson HJ
Am J Clin Pathol; 2020 Mar; 153(4):554-565. PubMed ID: 32011681
[TBL] [Abstract][Full Text] [Related]
11. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
Kárai B; Bedekovics J; Miltényi Z; Gergely L; Szerafin L; Ujfalusi A; Kappelmayer J; Hevessy Z
Int J Lab Hematol; 2017 Dec; 39(6):577-584. PubMed ID: 28625017
[TBL] [Abstract][Full Text] [Related]
12. Comparison of flow cytometry with other modalities in the diagnosis of myelodysplastic syndrome.
Pembroke JS; Joseph JE; Smith SABC; Parker AJC; Jiang W; Sewell WA
Int J Lab Hematol; 2022 Apr; 44(2):313-319. PubMed ID: 34841680
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single-centre real-life experience.
Majcherek M; Kiernicka-Parulska J; Mierzwa A; Barańska M; Matuszak M; Lewandowski K; Komarnicki M; Czyż A
Scand J Immunol; 2021 Aug; 94(2):e13028. PubMed ID: 33577137
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
[TBL] [Abstract][Full Text] [Related]
15. Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact.
Oelschlaegel U; Oelschlaeger L; von Bonin M; Kramer M; Sockel K; Mohr B; Wagenfuehr L; Kroschinsky F; Bornhaeuser M; Platzbecker U
Cytometry B Clin Cytom; 2023 Mar; 104(2):141-150. PubMed ID: 34390327
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry.
Clichet V; Lebon D; Chapuis N; Zhu J; Bardet V; Marolleau JP; Garçon L; Caulier A; Boyer T
Haematologica; 2023 Sep; 108(9):2435-2443. PubMed ID: 36924240
[TBL] [Abstract][Full Text] [Related]
17. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.
Cremers EM; Westers TM; Alhan C; Cali C; Visser-Wisselaar HA; Chitu DA; van der Velden VH; Te Marvelde JG; Klein SK; Muus P; Vellenga E; de Greef GE; Legdeur MC; Wijermans PW; Stevens-Kroef MJ; Silva-Coelho PD; Jansen JH; Ossenkoppele GJ; van de Loosdrecht AA;
Haematologica; 2017 Feb; 102(2):320-326. PubMed ID: 27658438
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndrome: validation of flow cytometry multilineage score system.
Araújo HV; Correia RP; Bento LC; Vaz ADC; Sousa FA; Alexandre AM; Schimidell D; Pedro EC; Ioshida MR; Barroso RS; Bacal NS
Einstein (Sao Paulo); 2020; 18():eAO4966. PubMed ID: 31994605
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1-tube panel strategy for diagnosis and prognosis of patients with MDS.
Barreau S; Green AS; Dussiau C; Alary AS; Raimbault A; Mathis S; Willems L; Bouscary D; Kosmider O; Bardet V; Fontenay M; Chapuis N
Cytometry B Clin Cytom; 2020 May; 98(3):226-237. PubMed ID: 31498561
[TBL] [Abstract][Full Text] [Related]
20. Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.
Rashidi HH; Xu X; Wang HY; Shafi NQ; Rameshkumar K; Messer K; Smith BR; Rose MG
Int J Clin Exp Pathol; 2012; 5(3):224-30. PubMed ID: 22558477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
